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ABSTRACT 21 
 Traditional fermented foods are the best source for the isolation of strains with specific 22 
traits to act as functional starters and to keep the biodiversity of the culture collections. 23 
Besides, these strains could be used in the formulation of foods claimed to promote health 24 
benefits, i.e. those containing probiotic microorganisms. For the rational selection of strains 25 
acting as probiotics, several in vitro tests have been proposed. In the current study, we have 26 
characterised the probiotic potential of the strain Lactobacillus paraplantarum BGCG11, 27 
isolated from a Serbian soft, white, homemade cheese, which is able to produce a “ropy” 28 
exopolysaccharide (EPS). Three novobiocin derivative strains, which have lost the ropy 29 
phenotype, were characterised as well in order to determine the putative role of the EPS in the 30 
probiotic potential. Under chemically gastrointestinal conditions, all strains were able to 31 
survive around 1-2% (10
6
 - 10
7
 cfu/ml cultivable bacteria) only when they were included in a 32 
food matrix (1% skimmed milk). The strains were more resistant to acid conditions than to 33 
bile salts and gastric or pancreatic enzymes, which could be due to a pre-adaptation of the 34 
parental strain to acidic conditions in the cheese habitat. The ropy EPS did not improve the 35 
survival of the producing strain. On the contrary, the presence of an EPS layer surrounding 36 
the strain BGCG11 hindered its adhesion to the three epithelial intestinal cell lines tested, 37 
since the adhesion of the three non-ropy derivatives was higher than the parental one and also 38 
than that of the reference strain Lactobacillus rhamnosus GG. Aiming to propose a potential 39 
target application of these strains as probiotics, the cytokine production of peripheral blood 40 
mononuclear cells (PBMC) was analysed.  The EPS-producing L. paraplantarum BGCG11 41 
strain showed an anti-inflammatory or immunosuppressor profile whereas the non-ropy 42 
derivative strains induced higher pro-inflammatory response.  In addition, when PBMC were 43 
stimulated with increasing concentrations of the purified ropy EPS (1, 10 and 100 g/ml) the 44 
cytokine profile was similar to that obtained with the EPS-producing lactobacilli, therefore 45 
pointing to a putative role of this biopolymer in its immune response.  46 
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1. Introduction 51 
Lactic acid bacteria (LAB) have been used for food fermentations since ancient times 52 
and some of them, due to their long history of safe use in human consumption, currently have 53 
the “Qualified Presumption of Safety” (QPS) status (EFSA, 2007). Nowadays functional 54 
cultures, which “contribute to food safety and/or offer one or more organoleptic, 55 
technological and nutritional, or health advantages”, have been widely implemented in the 56 
manufacture of fermented foods (Leroy and De Vuyst, 2004). In addition to the synthesis of 57 
lactic acid, there are several LAB traits that could confer desirable attributes to specific 58 
fermented products; this is the case of exopolysaccharide (EPS) production in dairy 59 
fermentations. Bacterial EPS are a large group of carbohydrate polymers which could be 60 
either covalently associated with the cell surface forming a capsule, or be loosely attached, or 61 
totally secreted into the environment of the cell (Ruas-Madiedo et al., 2008). The in situ 62 
synthesis of EPS by LAB cultures during milk fermentation improves the viscosity and 63 
texture of the fermented product since these biopolymers act as thickeners and emulsifiers or 64 
could also be fat replacers in low-caloric products. Besides, it seems that the synthesis of EPS 65 
could help the producing bacteria to survive adverse environmental conditions and it has been 66 
proposed that these polymers could promote some benefit for human health (Ruas-Madiedo et 67 
al., 2008). 68 
Apart from foods, several LAB genera such as Lactobacillus are naturally inhabitants 69 
of the gastrointestinal tract (GIT) of animals including the human gut (Margolles et al., 2009) 70 
where EPS-producing strains have also been isolated (Ruas-Madiedo et al., 2007; Tieking et 71 
al., 2005). The presence in this ecological niche of members of this genus is one of the 72 
reasons for which some lactobacilli species have been proposed as beneficial for human 73 
health. According to the definition proposed in 2001 by FAO/WHO expert consultation 74 
group, probiotics are defined as “live microorganisms which when administered in adequate 75 
amounts confer a health benefit on the host” (FAO/WHO, 2006). The concept of probiotic is 76 
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linked to strain level and it cannot be extended to species. Therefore, studying probiotic traits 77 
of new or commercial strains is of special relevance before their application in the 78 
formulation of functional foods (Jensen et al., 2012). For this purpose, a guideline has been 79 
proposed by FAO/WHO (2006) for testing the probiotic potential of a given strain based on 80 
several safety and health criteria which can be achieved by means of in vitro and/or in vivo 81 
approaches. Nevertheless, the efficacy of a probiotic formulation should be demonstrated by 82 
means of well designed double-blind, placebo controlled human clinical trials (FAO/WHO, 83 
2006). 84 
The EPS-producing strain Lactobacillus paraplantarum BGCG11 (formerly classified 85 
as Lactobacillus casei CG11) was isolated from soft, white, homemade cheese and showed a 86 
“ropy” phenotype, denoted by the formation of a long filament in the culture, which is due to 87 
the synthesis of EPS (Kojic et al., 1992). The biopolymer is a heteropolysaccharide mainly 88 
composed of glucose (76%) and rhamnose (21%) with some traces of galactose (Cerning et 89 
al., 1994). Preliminary studies revealed that genetic information for production of this EPS is 90 
possibly located in the 30 kb plasmid, since several novobiocin-cured (Muc
-
) derivative 91 
strains lacking this plasmid have lost their ropy character and were not able to produce 92 
significant amounts of EPS in comparison to the parental (Muc+) strain (Cerning et al., 1994; 93 
Kojic et al., 1992). The aim of the current work was to in vitro evaluate the EPS-producing L. 94 
paraplantarum BGCG11 strain and its derivatives as potential probiotics and to determine the 95 
putative role that the EPS could play in this feature. For this purpose, bacterial suspensions in 96 
milk of the parental BGCG11 and three Muc
- 
derivative strains were challenged to the 97 
chemically simulated GIT transit. Their ability to adhere to different epithelial intestinal cell 98 
lines and their capability to modify the proliferation and cytokine production by peripheral 99 
blood mononuclear cells (PBMC) were analysed as well.  100 
2. Material and Methods 101 
2.1. Bacterial growth and strain identification 102 
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 The EPS-producing ropy L. paraplantarum BGCG11 parental strain and its non-ropy 103 
(Muc
-
) derivatives obtained after treatment with novobiocin (strains NB1, NB4, NB16) were 104 
cultured in MRS broth (Merck, Darmstadt, Germany) at 30°C. Total DNA from these cultures 105 
was extracted and quantified using standard procedures. The determination of the species 106 
identity was performed by nucleotide sequencing using primers complementary to 16s rDNA: 107 
UNI16SF and UNI16SR (Jovcic et al., 2009). The discrimination among Lactobacillus 108 
plantarum, L. paraplantarum and Lactobacillus pentosus was carried out by multiplex PCR 109 
recA gene-derived primers plantF, pentF, and plantR as described (Torriani et al., 2001). All 110 
PCR amplifications were performed using the KAPA Taq DNA polymerase kit (Kapa 111 
Biosystems, MA, USA). Reaction mixtures contained: 20 mM Tris-HCl (pH 8.4), 50 mM 112 
KCl, 3 mM MgCl2, 50 mM each of the dNTPs, 1 U of Taq polymerase, 5 pM of each primer 113 
(for multiplex PCR 0.25 µM
 of each primer), and 0.1 μg of template DNA in a final volume 114 
of 50 μl. The PCR products were purified with QIAquick PCR Purification KIT (Qiagen, 115 
Hilden, Germany) and were sequenced by Macrogen (Seoul, Korea). The BLAST algorithm 116 
(http://www.ncbi.nlm.nih.gov/BLAST) was used to determine the most related DNA 117 
sequences in the NCBI GenBank database. The nucleotide sequence of 16S rDNA of the 118 
strain L. paraplantarum BGCG11 is held in the “European Nucleotide Archive” database 119 
(http://www.ebi.ac.uk/ena) with the accession number HE600693. Additionally, the strain was 120 
typed by AFLP method in the Laboratory for Microbiology, Ghent University (Ghent, 121 
Belgium).  122 
2.2. EPS extraction and  purification  123 
 For EPS extraction and purification, the ropy parental strain BGCG11 was 124 
grown in basal minimum media (BMM) containing amino acids, minerals, and vitamins 125 
(Cerning et al., 1994) and supplemented with 10 g/l saccharide-free Casamino Acids (Difco, 126 
Michigan, USA) and with 20 g/l glucose (see supplementary Table S1). Fresh medium was 127 
inoculated (10%, v/v) with overnight BMM-grown culture and incubated at 25 °C for 48 h. 128 
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After incubation, bacteria were removed by centrifugation (12,000 x g, 30 min, 4 °C) and EPS 129 
were extracted and precipitated at 4 °C for 48 h by adding 2 volumes of chilled absolute 130 
ethanol. The precipitate was collected by centrifugation (12,000 x g, 20 min, 4 °C), dissolved 131 
in distilled water and dialysed against water, using 12-14 kDa MWCO membranes (Sigma 132 
Chemical Co., St. Louis, MO, USA), for 24 h at 4 °C. The dialysed-retentate was freeze-dried 133 
to obtain the EPS-crude fraction which was additionally purified to reduce the DNA and 134 
protein content. For this purpose, the EPS-crude powder was dissolved in 50 mM Tris-HCl, 135 
10 mM MgSO4·7H2O (pH 7.5) at a final concentration of 5 mg/ml and treated with DNAse 136 
type-I (Sigma, final concentration 2.5 µg/m) for 6 h at 37 ºC, followed by Pronase E (Sigma, 137 
final concentration 50 µg/ml) treatment for 18 h at 37 ºC. Afterwards, TCA (12% final 138 
concentration) was added, to precipitate enzymes and residual amino acids or peptides, and 139 
the mixture was stirred at room temperature for 30 min. After centrifugation (12,000 x g, 20 140 
min, 4 ºC), the supernatant was collected, its pH adjusted to 4.0-5.0 with 10 M NaOH, 141 
dialysed against ultra-pure water (for 3 days, at 4 ºC with a daily change of water) and finally 142 
freeze-dried. The resulting lyophilised powder was the purified EPS-CG11 fraction, which 143 
was used in different concentrations for further analyses. The protein content of this EPS-144 
fraction was quantified by the BCA method (Pierce, Rockford, IL, USA), the DNA presence 145 
was determined using the Take3 Multi-volume Plate (Biotek Instruments GmbH, Bad 146 
Friedchshall, Germany) and the EPS content was determined by means of SEC-MALLS 147 
analysis, as indicated in the next section.    148 
 2.3. Simulated GIT transit of L. paraplantarum strains and the purified EPS-CG11  149 
The survival of L. paraplantarum BGCG11 parental strain and its Muc
-
 derivatives 150 
after the chemically simulated GIT transit was determined as described by Sánchez et al. 151 
(2010). In short, 24 h MRS-grown cultures were harvested, washed twice with 0.85% NaCl 152 
and concentrated 10-times in reconstituted (10%) sterilised skimmed-milk (BD, Difco®, 153 
Becton Dickinson, Franklin Lakes, NJ, USA). Afterwards, bacterial suspensions were diluted 154 
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10-times with gastric juice [GJ: 125 mM NaCl, 7 mM KCl, 45 mM NaHCO3, 0.3% 
 
Pepsine 155 
(Sigma) adjusted to pH 2 with HCl], incubated for 90 min at 37 ºC in aerobic conditions 156 
under stirring ( 200 rpm). Then, bacterial suspensions were centrifuged (2,050 xg, 15 min), 157 
resuspended in duodenal juice [DJ: 1% bovine bile (Sigma) adjusted with 10 M NaOH to pH 158 
8.0] and incubated for 10 min at 37 ºC in anaerobic chamber MG500 (Don Whitley Scientific, 159 
West Yorkshire, UK) under 10% (v/v) H2, 10% CO2 and 80% N2 atmosphere. Finally, 160 
harvested cell suspensions were resuspended in intestinal juice [IJ: 0.3% bovine bile, 0.1% 161 
Pancreas acetone powder porcine Type I (Sigma), pH 8.0] and incubated for 120 min at 37 ºC 162 
in anaerobic conditions. Two samples were collected during IJ challenge, after 60 min and 163 
120 min. Determination of viable counts was carried out in the initial cultures and after each 164 
of the GJ, DJ and IJ challenges. Serial dilutions of the samples were made in Ringer´s 165 
solution (Merck) and pour-plated into agar-MRS. Plates were incubated for 48 h at 30 ºC and 166 
results were expressed as cfu/ml. The percentage of survival was calculated from the viable 167 
counts recovered after each chemically simulated GIT step with respect to the initial counts 168 
(% cfu recovered bacteria / cfu initial bacteria). Experiments were carried out in triplicate. 169 
 The simulated transit through GIT of isolated EPS was performed according to Salazar 170 
et al. (2009b). Briefly, the EPS-purified fraction was dissolved in ultra-pure water (Sigma) at 171 
10 mg/ml and submitted to independent GJ and DJ stresses. In both cases, 100 l of EPS 172 
solution was mixed with either 900 l of GJ or DJ and incubated under conditions previously 173 
described for both challenges. Afterwards, samples were collected and stored at -80 ºC before 174 
EPS-degradation analysis. In the case of the GJ samples, the pH was increased until 4.5 ± 0.5 175 
with 10 M NaOH before storage. The hydrolysis of the EPS-purified fractions was assessed 176 
by means of size exclusion chromatography (SEC) coupled with a multi-angle laser light 177 
scattering (MALLS) detector. The chromatographic system (Waters, Milford, MA, USA) was 178 
composed of an Alliance 2690 module injector, a Photodiode Array PDA 996 detector 179 
(checked at 220 and 280 nm for protein detection or 260 nm for DNA detection), a 410 180 
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refractive index (RI) detector and the Empower software (Waters). The RI detector allowed us 181 
to determine the amount of EPS present in the sample using calibration curves made with 182 
dextran standards (Salazar et al, 2009a). Additionally, the MALLS detector (Dawn Heleos II, 183 
Wyatt Europe GmbH, Dembach, Germany) was coupled in series and the software Astra 3.5 184 
was used for molar mass distribution analysis. Separation was carried out in two SEC 185 
columns placed in series, TSK-Gel G3000 PWXL + TSK-Gel G5000 PWXL protected with a 186 
TSK-Gel guard column (Supelco-Sigma) at 40 ºC, flow rate 0.45 ml/min using  0.1 M NaNO3 187 
as mobile phase. Experiments were repeated three times. 188 
2.4. Adhesion of L. paraplantarum strains to intestinal cell lines 189 
The colonocyte-like cell lines Caco2, HT29 and HT29-MTX were used to determine 190 
the adhesion ability of the parental and the three Muc- L. paraplantarum derivative strains, 191 
using Lactobacillus rhamnosus LMG18243 (also named GG) as reference strain. L. 192 
paraplantarum strains were grown in MRS broth, under conditions previously described, and 193 
strain GG was grown in MRS supplemented with 0.05% L-cysteine (Sigma) at 37 ºC, 5% CO2 194 
in a Heracell 240 incubator (Thermo Electron LDD GmbH, Langenselbold, Germany). 195 
Caco2 and HT29 were purchased from the European Collection of Cell Cultures 196 
(ECACC No. 86010202 and 91072201, respectively) and HT29-MTX was kindly supplied by 197 
Dr. T. Lesuffleur (Lesuffleur et al., 1990). The culture and maintenance of the cell lines were 198 
carried out following standard procedures (Sánchez et al., 2010) using DMEM medium for 199 
Caco2 and HT29-MTX, and McCoy´s medium for HT29, supplemented with foetal bovine 200 
serum and with a mixture of antibiotics (50 g/ml penicillin, 50 g/ml streptomycin, 50 g/ml 201 
gentamicin and 1.25 g/ml amphotericin B). Media and reagents were purchased from Sigma. 202 
Intestinal cells were seeded in 24-well plates and cultivated until a confluent differentiated 203 
state was reached. For adhesion experiments, 13±1 day-old cellular monolayers were used. 204 
Lactobacilli were cultured for 24 h and after washing twice with Dulbecco´s PBS 205 
solution (Sigma) were resuspended in the corresponding cell-line media without antibiotics at 206 
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a concentration of about 10
8
 cfu/ml. Cellular monolayers were also carefully washed and 207 
bacterial suspensions were added at a ratio of about 10:1 (bacteria: eukaryotic cell). Adhesion 208 
experiments were carried out for 1 h at 37 °C, 5% CO2 and, afterwards, wells were gently 209 
washed to release unattached bacteria before proceeding with the lysis of cellular monolayers 210 
using 0.25% Trypsin–EDTA solution (Sigma). Dilutions of samples, before and after 211 
adhesion, were made in Ringer´s solution and bacterial counts were performed in agar-MRS. 212 
The adhesion was calculated as: % cfu adhered bacteria /cfu added bacteria. Experiments 213 
were carried out in two replicated plates and in each plate two wells were used per sample. 214 
2.5. Proliferation and cytokine production of PBMC in the presence of non-viable L. 215 
paraplantarum strains or the EPS-CG11 purified fraction 216 
Human PBMC were obtained from buffy-coats from routine blood donors (Asturian 217 
Blood Transfusion Center, Oviedo, Spain) after the approval of the Regional Ethics 218 
Committee for Clinical Investigation (Asturias, Spain). PBMC were isolated by centrifugation 219 
over Histopaque-1077 gradient (Sigma) of buffy-coats from 6 healthy donors. PBMC were 220 
cultured in RPMI-1640 medium, containing 2 mM L-glutamine, 25 mM Hepes (PAA, 221 
Pasching, Austria), 10% (v/v) heat-inactivated foetal bovine serum (PAA) and supplemented 222 
with streptomycin and ampicillin (100 μg/ml).  223 
The PBMC response to the four UV-irradiated lactobacilli, as well as to different 224 
concentrations (1, 10 and 100 µg/ml) of the EPS-CG11, was determined according to López 225 
et al. (2010) as follows: 2×10
4
 PBMC suspended in 200 l of RPMI medium were co-226 
incubated with bacteria at a ratio of 1:5 (PBMC: bacteria) or with EPS for 4 days at 37 ºC, 5% 227 
CO2. PBMC cultured in complete RPMI media and in the presence of 0.05 g/ml 228 
lipopolysaccharide (LPS) from E. coli 0111:B4 (Sigma) were used as negative and positive 229 
proliferation controls, respectively. Each stimulus and control was tested in triplicate wells 230 
per PBMC donor, using 96-well round-bottom microtiter plates (Costar, Cambridge, MA, 231 
USA). After 4 days of incubation, 20 μl supernatants of each replicate-well were collected, 232 
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mixed and stored at -20ºC before being used for cytokine analysis. The same volume of 233 
complete RPMI medium containing 10 M (final concentration) BrdU label (GE Healthcare 234 
Ltd., Buckinghamshire, UK) was added and incubation was continued for 18 h. After this 235 
time, eukaryotic cells were collected by centrifugation, fixed and their proliferation was 236 
determined using the Amersham Cell Proliferation Biotrack ELISA system (GE Healthcare 237 
Ltd.) following the manufacturer´s instructions. The colorimetric reaction was measured at 238 
450 nm in a Modulus Microplate photometer (Turner Biosystems, CA, USA) and the 239 
proliferation index (PI) obtained for each stimulus was referred to the negative control (that is, 240 
the proliferation index of the control is 1). 241 
The cytokine production from PBMC co-cultures was quantified by means of the 242 
multiplex immunoassay Flex Set for CBA (Cytometric Bead Array) including IFNγ, TNFα, 243 
IL-12, IL-8, IL-10, IL-1β and IL-17 (Becton Dickinson, BD Biosciences, San Diego, CA). 244 
The FacsCantoII flow cytometer and the FCAP array software (BD Biosciences) were used 245 
for analysis. The detection limits were: 0.8 pg/ml (IFNγ), 3.7 pg/ml (TNFα), 1.9 pg/ml (IL-246 
12p70), 3.6 pg/ml (IL-8), 3.3 pg/ml (IL-10), 7.2 pg/ml (IL-1β), and 0.3 pg/ml (IL-17). 247 
2.6. Statistical analysis 248 
 The SPSS 15.0 software for Windows (SPSS Inc., Chicago, IL, USA) was used for 249 
statistical analyses. Data of chemically simulated GIT transit, bacterial adhesion to epithelial 250 
cell lines and PBMC proliferation were normally distributed and therefore they were analysed 251 
by means of independent one-way ANOVA tests. When necessary, the mean comparison test 252 
LSD (least significant difference, p < 0.05) was used. The cytokine production by PBMC was 253 
analysed by the non-parametric Mann-Witney test for two independent samples comparing 254 
values obtained for each stimulus with respect to that of the negative control (PBMC cultured 255 
in RPMI).  256 
3. Results  257 
3.1. Identification of L. paraplantarum strains 258 
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The strain BGCG11 was previously classified as L. casei (Kojic et al., 1992). 259 
However, the results obtained in this study revealed that the 16S rDNA sequence of 260 
BGCG11strain showed 99% identity with sequences of L. plantarum and L. pentosus. The 261 
multiplex PCR with recA gene-derived primers, which allows differentiation among L. 262 
plantarum, L. pentosus and L. paraplantarum species, was performed and an amplicon of 107 263 
bp corresponding with that expected for L. paraplantarum was obtained (data not shown). 264 
Additionally, the AFLP fingerprinting showed that the resulting profile corresponded to that 265 
of this species. These results enabled the re-classification of the parental strain BGCG11 and 266 
its Muc- derivatives NB1, NB4 and NB16 strains as L. paraplantarum species.  267 
3.2. In vitro GIT survival and intestinal adhesion of L. paraplantarum strains 268 
The ropy EPS-producing L. paraplantarum BGCG11 and its non-ropy derivative 269 
strains tested in this study were able to survive GIT challenges only when bacteria were 270 
suspended in skimmed milk (Figure 1). They did not survive when bacterial suspensions were 271 
made in buffered solution (data not shown). The survival percentage of bacteria in milk 272 
suspensions to gastric digestion was around 80% for all strains tested, which indicates that L. 273 
paraplantarum was resistant to acidic conditions. In addition, a short exposure time to high 274 
bile salts concentrations (1%) decreased the survival up to 70%. However, prolonged 275 
exposure times to lower bile concentrations (0.3%) and pancreatic enzymes drastically 276 
reduced the bacterial viability. The final survival rate varied between 1 and 2% (10
6
 to 10
7
 277 
cfu/ml), the highest (p<0.05) being that of the derivative NB1 strain (initial Log cfu/ml: 278 
parental BGCGG11 8.5 ±0.1, derivatives NB1 9.1±0.01, NB4 8.9±0.1 and NB16 8.9±0.1).  279 
The protein content of the initial lyophilised EPS-CG11 was 1.970.17 % and no 280 
DNA was detected using either the Take3-Multi-volume Plate or the PDA detector (260 281 
nm) of the HPLC. Using data from the SEC-MALLS analysis, it has been estimated  that the 282 
polymer content was 98.251.02% and it was found that the EPS-CG11 presented two peaks 283 
of different size (see supplementary Figure S1); the highest peak had a molar mass about 284 
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2.2x10
6
 Da (peak abundance 89.3%)  and the smallest about 5.6x10
4
 Da (abundance 10.7%). 285 
The presence of more than one fraction of different size was previously reported in different 286 
EPS synthesised by strains of food origin (Sánchez et al., 2005; Vaningelgem et al., 2004) and 287 
human origin (Salazar et al., 2009a).  In order to check whether GIT challenges have modified 288 
the physico-chemical characteristics of the EPS-CG11 was submitted the native polymer to 289 
gastric or intestinal digestion. The SEC-MALLS analysis of challenged polymer showed that 290 
the amount of the highest-peak EPS-CG1, as well as its molar mass, remained without 291 
statistical noticeable modifications (Table 1). This indicates that EPS-CG11 was stable under 292 
simulated GIT digestion.  293 
The adhesion ability of parental strain BGCG11 and its derivatives to the epithelial 294 
intestinal cell lines Caco2, HT29 and HT29-MTX was determined in order to denote possible 295 
differences related with the production of a ropy-EPS by the BGCG11 strain. L. rhamnosus 296 
GG was used as the positive reference strain, since it has well recognised adherence to 297 
intestinal mucosa and is a strain widely included in many probiotic foods. In general, the 298 
adhesion properties of the five strains tested followed the same tendency in the three intestinal 299 
cell lines, although lower percentages of adhesion were detected for the mucus-producing 300 
HT29-MTX cell line (Figure 2). Probably, the presence of the glycoprotein (mucin) layer in 301 
this cellular line hinders the availability of cells receptors for bacteria. The non-ropy 302 
derivatives L. paraplantarum NB1, NB4 and NB16 were able to adhere significantly (p<0.05) 303 
better than the reference strain GG in all cell lines, having adhesion percentages ranging from 304 
5% to 25%. On the contrary, the parental L. paraplantarum BGCG11 showed similar (HT29 305 
and HT29-MTX) or lower (Caco2, p<0.05) adhesion ability than L. rhamnosus GG (which 306 
was around 3%). Therefore, these results showed that the non-ropy derivatives had a better 307 
adherence trait than the parental strain and the reference strain GG, pointing to a possible 308 
involvement of the EPS interfering with the interaction with epithelial intestinal cells.  309 
3.3. In vitro response of PBMC elicited by L. paraplantarum strains and EPS-CG11 310 
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The capability of the L. paraplantarum BGCG11 and its derivatives, inactivated by 311 
UV-radiation, as well as the purified EPS-CG11 at three concentrations (1, 10 and 100 g/ml) 312 
to elicit immune response was tested upon PBMC isolated from six healthy human donors. 313 
The proliferation indexes of PMBC measured in the presence of these stimuli and LPS (0.05 314 
g/ml) from E. coli, as positive control, showed that all bacterial strains were able to 315 
significantly (p<0.05) increase the proliferation of PBMC in comparison with the control 316 
(RPMI in the absence of stimulus, Table 2). On the contrary, neither the LPS from E. coli nor 317 
the EPS-CG11 at any concentration modified the proliferation of PBMC.  318 
  The cytokine production pattern of PBMC co-cultured for 4 days with the different 319 
previously described stimuli shows that, in general, the four L. paraplantarum strains showed 320 
significantly higher (p<0.05) levels of all cytokines tested than the negative control sample 321 
(RPMI without stimulus) except for the IL-17 production (Figure 3). The comparison of each 322 
strain with respect to the control showed that the parental EPS-producing strain BGCG11 did 323 
not modify the IL-12 levels, whereas the derivative strains significantly increased the levels of 324 
this cytokine. Statistical comparisons among the four strains, showed significantly (p<0.05) 325 
lower levels of TNF- and IL-12 only for the parental strain, whereas no significant 326 
differences were observed among BGCG11 and its derivatives for the rest of analyzed 327 
cytokines. The response of PBMC stimulated with different concentrations of the purified 328 
EPS-CG11 showed lower production of all cytokines, except IL-17, in comparison with that 329 
produced by the lactobacilli strains. Thus, this polymer induced a lower immune response 330 
than the whole bacterium. However, an EPS-dose effect was detected since most cytokines 331 
increased levels in the presence of higher concentrations of EPS. Specifically, we observed a 332 
significant increase of the IL-10 and IL-1 production (p<0.05) at the highest (100 g/ml) 333 
EPS concentration tested compared with the negative (RPMI medium) control.  334 
Aiming to propose specific target applications, the type of T-helper (Th) response that 335 
the four L. paraplantarum strains or the EPS-CG11 could induce was evaluated; for this, 336 
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different ratios between cytokines that are relevant for T cell differentiation were calculated: 337 
TNF-/IL-10 (pro-Th1, i.e. inflammatory response), IL-10/IL-12 (pro-Th2 -Treg, i.e. anti-338 
inflammatory or suppressor response) and IL-1/IL-12 (pro-Th17, i.e. relevant for immune 339 
mucosa defence), as in healthy individuals, these T cell subsets are adequately balanced.  340 
From these observed ratios it seems that, although no statistical differences were detected 341 
among strains (p>0.05), the parental EPS-producing strain BGCG11 presented the highest IL-342 
10/IL-12 ratio (pro-Th2-Treg) as well as an increased IL-1β/IL-12 proportion (pro-Th17 343 
response), whereas the non-ropy derivatives showed a pro-Th1 profile (Table 3). In fact, the 344 
parental strain was the only one that presented a significantly (p<0.05) higher Th2-Treg ratio 345 
compared with the negative control. Besides, it is worth mentioning that the immune response 346 
elicited upon PBMC by purified EPS followed the same pattern as that of the EPS-producing 347 
strain, although the differences with respect to the control were statistically significant 348 
(p<0.05) only at the highest EPS dose (100 g/ml).  349 
 350 
4. Discussion 351 
According to the FAO/WHO guideline for the evaluation of probiotics for human food 352 
applications (FAO/WHO, 2006), the bacterial survival of gastric and intestinal digestion is 353 
one of the most desirable properties that strains with probiotic potential should present. The 354 
performance of the ropy L. paraplantarum BGCG11 parental strain, isolated from a home-355 
made cheese, and its non-ropy derivatives challenged against the adverse conditions of the 356 
GIT, was adequate taking into account that from a initial 8 Log cfu/ml units, a final 6 Log 357 
units still remained in cultivable conditions (around 1-2% survival). The highest survival rate 358 
was that of the derivative NB1 strain, which could be due to the slightly higher initial number 359 
of cells challenged in this strain in comparison with the other three. In addition, it is important 360 
to note that these survival rates were only achieved when bacteria were included in a food 361 
matrix (1% skimmed milk). It has previously been reported that the delivery of bacteria in 362 
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food carriers favours survival through the GIT due to the buffering and protective effect of the 363 
food components (Ranadheera et al., 2010).This fact underlines the relevance of the food 364 
carrier selection for each specific strain which could as well be related with the original 365 
source of bacteria. Our L. paraplantarum were resistant to low pH conditions, which could be 366 
due to a pre-adaptation to acid conditions in the natural environment from which the parental 367 
strain was isolated (Terzic-Vidojevic et al., 2007). Similar behaviour to GIT challenge was 368 
reported for other food-origin lactobacilli strains, such as Lactobacillus delbrueckii subsp. 369 
lactis (Burns et al., 2011). Against this, the survival of our L. paraplantarum strains quickly 370 
declined in the presence of bile salts and pancreatic enzymes, stress factors that isolates of 371 
food-origin do not encounter in their natural environment. This could lead to the conclusion 372 
that food-origin strains could be less adaptable to the human gut environment, although from 373 
previous reports this correlation is not clear (Gaudana et al., 2010; Lee et al., 2011). Indeed, it 374 
seems that independent of the ecological niche from which the strains were isolated, both acid 375 
and bile resistance are species- and/or strain-dependent traits (Lo Curto et al., 2011; Mathara 376 
et al., 2008). Regarding the putative role of EPS in the protection of the producing strain 377 
during GIT transit, it seems that the polymer itself was not digested during the challenges. 378 
This has been reported for other purified EPS synthesised by LAB and bifidobacteria, which 379 
are stable to harsh conditions probably due to their intrinsic resistance to acid hydrolysis 380 
(Salazar el al., 2009b). However, the polymer cover present on the surface of the EPS-381 
producing  strain L. paraplantarum BGCG11 was not effective enough to increase its survival 382 
in comparison with the non-ropy derivatives, as also occurred for the EPS-producing strains 383 
L. delbrueckii subsp. lactis 193 and 193+ (Burns et al., 2011). Similarly, the EPS envelope of 384 
strains Bifidobacterium longum NB667 and 667Co did not improve their survival when in 385 
vitro challenged to human-origin gastric and duodenal juices. In contrast, the EPS layer 386 
surrounding several Bifidobacterium animalis subsp. lactis strains was effective in keeping 387 
the number and viability of bacterial cells after simulated GIT transit (de los Reyes-Gavilán et 388 
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al., 2011). Thus, the capability of EPS surrounding the producing-bacteria to deal with the 389 
harsh conditions of the upper-part of the gut tract seems to be both polymer and strain 390 
dependent. In this regard, it has been already indicated that the EPS physico-chemical 391 
characteristics, intrinsic to each polymer type, must account for their biological, technological 392 
and protective abilities (Ruas-Madiedo et al., 2008). Additionally, EPS production has been 393 
proposed as one of the mechanisms that bacteria, including lactobacilli, trigger in presence of 394 
GIT challenges (Burns et al., 2010).   395 
Another criterion proposed by FAO/WHO guideline for the selection of strains with 396 
probiotic potential is their ability to transiently colonise the intestinal mucosa. Several in vitro 397 
and in vivo models have been used to this aim and, through several of these approaches, it has 398 
been shown that the strain L. rhamnosus GG has good adherence to intestinal mucosa 399 
(Laparra and Sanz, 2009; Vesterlund et al., 2005). Thus, we have used GG strain as the 400 
reference to compare the performance of our L. paraplantarum strains regarding their ability 401 
to adhere to three intestinal epithelial cell lines. These cell lines express morphological and 402 
functional differentiated characteristics resembling that of mature enterocytes (Jumarie and 403 
Malo, 1991; Lesuffleur et al., 1990). Results obtained with this model showed that our non-404 
ropy L. paraplantarum derivatives NB1, NB4 and NB16 had a remarkably better adhesion 405 
trait than that of the ropy parental BGCG11 strain or that of the L. rhamnosus GG reference 406 
strain. In this way, it has also been detected that an isogenic EPS-mutant (strain CMPG5351) 407 
of L. rhamnosus GG, which has lost the ability to produce big-size galactose-rich EPS and 408 
produces only small-size glucose-rich cell-wall associated polysaccharides, had increased 409 
adherence to mucus and Caco-2 monolayer cells in comparison to the parental GG (Lebeer et 410 
al., 2009). Similarly, a mutant of Lactobacillus johnsonii NCC533, with deleted EPS 411 
biosynthesis genes, persisted longer in the murine gut presumably because of enhanced 412 
exposure of its adhesins (Denou et al., 2008). However, Lebeer et al. (2011) using the same 413 
EPS-mutant from L. rhamnosus GG have found lower persistence of the EPS-mutant strain 414 
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than the parental GG strain in an in vivo murine model, which contradicted the previous in 415 
vitro findings of the same authors. It seems that in vivo, the EPS synthesized by strain GG 416 
form a protective shield against innate antimicrobial molecules synthesized by the host cells. 417 
Therefore, the role of bacterial EPS in the colonization of intestinal mucosa is still not clear. It 418 
seems that in some cases the EPS envelope covering the producing strains could hinder 419 
bacterial adhesion to enterocytes, whereas in its absence other surface molecules could have 420 
been exposed and therefore acted as adhesins. Nevertheless, EPS could also be involved in 421 
persistence of producing bacteria by acting as protective molecules against antimicrobial 422 
molecules. Besides, and taking into account the citations reported above, the model used to 423 
test the ability of any potential probiotic strain to transiently colonize the GIT is of pivotal 424 
relevance. 425 
Nowadays, it is well known that probiotics impact on the immune function of humans 426 
by inducing T-cell differentiation to Th1, Th2, Th17 or Treg (Dong et al., 2010; López et al., 427 
2011). Therefore, it is claimed that they promote health benefits throughout the regulation of 428 
the immune response, However, it is necessary to underline that the immune modulation 429 
ability is strictly species- and strain-dependent (Díaz-Ropero et al., 2007; van Hemert et al., 430 
2010), that for a given strain it is dose-dependent (Evrard et al., 2011) and that well 431 
documented probiotics are not effective for all human populations (Seifert et al., 2011). In the 432 
current study, we have demonstrated that the closely related parental L. paraplantarum 433 
BGCG11 strain and its novobiocin-cured NB1, NB4 and NB16 elicited different immune 434 
response patterns upon human PBMC. The parental BGCG11 strain had increased cytokine 435 
ratios suggestive of Th2-Treg and Th17 response, the first involved in suppressive and 436 
immunoregulatory functions and the last one being of special relevance for the immune 437 
mucosa homeostasis. Although, both T-cell populations seem to be implicated in antagonistic 438 
functions, it is known that Th17 and Treg cells share common cytokine signaling pathways 439 
allowing plasticity in their polarization. Thus, Treg cells are able to produce IL-17 and 440 
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assume a Th17 function when they are activated in the presence of pro-inflammatory 441 
cytokines, such as IL-1β (Yang et al., 2008). Interestingly, these data are in agreement with 442 
previous results of our laboratory supporting such Treg/Th17 plasticity induced by the strain 443 
Bifidobacterium bifidum LMG13195 (López et al., 2011). In the current study, and conversely 444 
to the parental BGCG11 strain, we have detected that the non-ropy L. paraplantarum 445 
derivatives induced a pro-Th1 cytokine pattern. Thus it seems that the parental and derivative 446 
strains showed an opposite immune response tendency. The main difference among these 447 
strains is the production of a ropy, big-size EPS in the parental one, which suggests that the 448 
EPS produced by L. paraplantarum BGCG11 could play a role in the suppression of the 449 
immune response induced by the parental strain. Thus, we hypothesize that the EPS-CG11 450 
could act as an effector molecule regulating the differential immune response. In fact, this 451 
seemed to be corroborated when PBMC were co-incubated with different concentrations of 452 
the purified EPS-CG11. An EPS dose-effect was detected, showing a similar immune profile 453 
to that of the L. paraplantarum EPS-producing strain. The physico-chemical characteristics of 454 
EPS-CG11 revealed that it is a big-size polymer (around 2x10
6
 Da) and previous work 455 
showed that it was mainly composed of glucose (75.7%) and rhamnose (20.5%), with traces 456 
of galactose (2.1%), and having a neutral character (Cerning et al., 1994). Thus, it seems that 457 
the EPS-CG11 surrounding the producing bacteria down-regulated the immune response, 458 
whereas in the non-ropy derivatives the absence of this polymer layer could expose other 459 
surface molecules which triggered a type Th1 (pro-inflammatory) response. Similar results 460 
have recently been obtained with EPS differing in size produced by closely related B. 461 
animalis subsp. lactis strains as indicated by López et al. (2012). Indeed, these authors 462 
suggest that EPS of high size have the ability to act as immune suppressor molecules, whereas 463 
small polymers are able to elicit an increased response.  464 
 465 
5. Conclusion 466 
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Taking all these results together, it could be concluded that the EPS-producing L. 467 
paraplantarum BGCG11 and its novobiocin derivatives NB1, NB4 and NB16 had different in 468 
vitro biological and functional properties, probably due to the presence of the EPS layer 469 
surrounding the parental strain. Although the in vitro and in vivo results cannot be directly 470 
extrapolated the stains tested in this study could have specific probiotic applications for 471 
human consumption. Taking into account the immune parameters, the parental BGCG11 472 
strain, with anti-inflammatory or immunosuppressor profile, could be included in the diet of 473 
patients suffering diseases associated with an increased inflammatory status, such as allergy 474 
and inflammatory bowel disease or other auto-immune disorders, as well as in functional 475 
foods formulated for the elder population. However, following the FAO/WHO criteria and 476 
EFSA recommendations, is necessary to underline that the safety and health promoting 477 
efficacy of such as functional foods need to be proven in human clinical trials. 478 
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Table 1. Stability of the highest peak of EPS-CG11 (see supplementary Figure S1) submitted 632 
to different chemically simulated gastrointestinal tract (GIT) conditions. No statistical 633 
differences among challenges were obtained after one-way ANOVA and by the LSD mean 634 
comparison tests.  635 
 636 
 637 
 638 
 639 
 640 
 641 
 642 
 643 
 644 
 645 
* amount of EPS (g) in the HPLC-injection volume (30 l) 646 
647 
 GIT challenge  Mean ±SD 
Amount (g)* Initial 
Gastric juice 
Intestinal juice 
261.5±2.9
 
 
285.5±7.8 
255.6±7.9
 
 
Molar Mass (x10
6
 Da) Initial 
Gastric juice 
Intestinal juice 
2.2±0.6 
2.3±0.3 
2.3±0.8 
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 648 
Table 2. Proliferation index (PI) of peripheral blood mononuclear cells (PBMC), isolated 649 
from six healthy donors, co-cultured for 4 days in presence of the ropy Lactobacillus 650 
paraplantarum BGCG11 and its non-ropy derivatives NB1, NB4 and NB16, as well as in the 651 
presence of three concentrations (1, 10 and 100 g/ml) of the EPS-CG11 or 0.05 g/ml of 652 
LPS from E. coli. Independent one-way ANOVA tests were carried out to compare the PI of 653 
each stimulus with respect to that of the control (RMPI medium without stimuli, PI =1).  654 
 655 
 656 
 657 
 658 
 659 
 660 
 661 
 662 
 663 
 664 
 665 
 666 
 667 
 668 
 669 
* p<0.05, ** p<0.01, *** p<0.001 670 
671 
  PI 
Stimuli  Mean ±SD 
LPS E. coli 0.05 g/ml 0.96±0.30  
Lb. paraplantarum BGCG11 
NB1 
NB4 
NB16 
1.12±0.16 ** 
1.14±0.28 * 
1.23±0.17 *** 
1.23±0.18 *** 
EPS-CG11 1 g/ml 
10 g/ml 
100 g/ml 
1.04±0.15  
1.00±0.15  
1.10±0.26  
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Table 3. Ratios calculated from the cytokines produced by peripheral blood mononuclear 672 
cells (PBMC), isolated from six healthy donors, co-cultured for 4 days in presence of the UV-673 
irradiated ropy Lactobacillus paraplantarum BGCG11 and its non-ropy derivatives NB1, 674 
NB4 and NB16, as well as in the presence of three concentrations (1, 10 and 100 g/ml) of 675 
the EPS-CG11 and 0.05 g/ml of LPS from E. coli. Independent non-parametric Mann-676 
Whitney for 2-independent samples tests were carried out to compare the ratio obtained for 677 
each stimulus with respect to that of the control (RPMI medium without stimuli). Differences 678 
with respect to the control are marked with asterisks (* p<0.05).   679 
 680 
 Cytokine ratios (mean ±SD) 
Stimuli TNF-/ IL-10 IL-10/ IL-12 IL-1/ IL-12 
RPMI (control) 
LPS 
4.28±3.63 
1.39±1.13  
0.89±0.21 
29.13±17.71 * 
2.37±1.61 
325.95±258.92 * 
Strain BGCG11 
Strain NB1 
Strain NB4 
Strain NB16 
133.58±98.33 * 
271.68±244.21 * 
321.01±322.34 * 
274.94±227.43 * 
34.88±38.34 * 
14.91±14.02 
11.54±11.85 
14.69±14.01 
1074.51±864.45 * 
510.78±435.98 * 
438.27±473.11 * 
515.35±528.76 
EPS-CG11 (1 g/ml) 
EPS-CG11 (10 g/ml) 
EPS-CG11 (100 g/ml) 
1.24±0.23 
1.54±0.47 
1.40±0.61 
0.93±0.27 
0.87±0.10 
1.51±0.28 * 
0.89±0.10  
1.47±0.23  
9.89±4.48 * 
681 
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Figure legends 682 
Figure 1. Survival percentage of the bacterial suspensions made in 10% skimmed-milk of the 683 
ropy Lactobacillus paraplantarum BGCG11 and its non-ropy derivatives NB1, NB4 and 684 
NB16 after chemically simulating the gastrointestinal tract (GIT) transit. GJ: gastric juice, DJ: 685 
duodenal juice, IJ: intestinal juice. Within each GIT challenge, columns that do not share the 686 
same letter are statistically different (p<0.05), accordingly to one-way ANOVA and the LSD 687 
mean comparison tests.  688 
 689 
Figure 2. Adhesion to the human epithelial intestinal cell lines Caco2, HT29 and HT29-MTX 690 
of the ropy Lactobacillus paraplantarum BGCG11 and its non-ropy derivatives NB1, NB4 691 
and NB16, as well as the reference strain Lactobacillus rhamnosus GG. Within each cell line, 692 
columns with an asterisk are statistically different (p<0.05) from the reference strain GG, 693 
accordingly to one-way ANOVA tests. 694 
 695 
Figure 3. Cytokines (pg/ml) produced by peripheral blood mononuclear cells (PBMC), 696 
obtained from six healthy donors, co-cultured for 4 days in the presence of the ropy 697 
Lactobacillus paraplantarum BGCG11 and its non-ropy derivatives NB1, NB4 and NB16 at 698 
ratio 5:1 (bacteria: cell line) (a), as well as in the presence of three concentrations (1, 10 and 699 
100 g/ml) of the purified EPS-CG11 (b). The LPS from E. coli (0.05 g/ml) was used as 700 
positive control. The “box and whiskers” figure represents median, inter-quartile range and 701 
minimum and maximum values. The statistical differences (p<0.05) between each stimuli and 702 
the control (RPMI) were assessed by means of the non-parametric Mann-Whitney test for 2-703 
independent samples, and they are indicated with asterisks.  704 
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 Supplementary Material 
Table S1. Composition of the basal minimum medium (BMM) used to grow the strain 
Lactobacillus paraplantarum BGCG11 for the extraction and purification of its EPS fraction.  
 
Component per L 
Casamino acids* 20 g 
Glucose 20 g 
Sodium acetate 6 g 
Ammonium citrate 1 g 
K2HPO4 3 g 
KH2PO4 3 g 
MgSO4 · 7H2O 0.5 g 
MnSO4 · 1H2O 0.032 g 
FeSO4 · 7H2O 0.02 g 
Riboflavine  1 mg 
Biotine 1 mg 
Folic acid 0.1 mg 
Nicotinic acid 1 mg 
Pantothenic acid 1 mg 
Pyridoxine 2 mg 
Para Aminobenzoic acid 0.2 mg 
Tween 80 1 mg 
 pH 6.8 
* Casamino acids from Difco, Detroit, MI, USA  
  
e-component
Figure S1. Size exclusion chromatography (SEC) analysis of the EPS synthesised by the strain 
Lactobacillus paraplantarum BGCG11, purified according to the procedure described in material 
and methods section. The lyophilised EPS was dissolved (10 mg/ml) in 0.1 M NaNO3 and the 
separation (30 l volume injection) was carried out in the columns and HPLC system described. 
The figure shows a chromatogram example where the blue line correspond to the multi-angle laser 
light scattering (MALLS) detector, set in position 11 (angle 90), the red line correspond to the 
refraction index (RI) detector and the green line correspond to the photodiode array (PDA) detector 
set at 280 nm. The results presented in the table are the average of three independent injections. The 
ASTRA software (Wyatt Europe GmbH, Dembach Germany) was used to analyse results obtained 
from MALSS detector using the random coil adjust-model.  
The peak 1 was not analysed since no signal in the RI was found; probably, the signal detected in 
the MALLS was due to the aggregation of some polymer particles [peak 1: weight average molar 
mass (Mw) about 1.7x10
8
 g/mol and weight average radius of gyration (Rw) about 62 nm].  
In the peaks 2 and 3, the PDA detector set at 220 nm and 260 nm (detection of peptidic linkage and 
DNA, respectively) was not giving signal and that at 280 nm (detection of aromatic amino acids) 
was very weak; thus, we assume that the RI signal of these peaks corresponds to EPS-fractions of 
polymer. Results of each peak, obtained from data of MALLS and RI, are collected in the table. 
 
 
 
 Mean  SD (n=3) 
 Peak 2 Peak 3 
Elution time (min) 
Amount (g) 
Abundance (%)
a
 
Concentration (mg/ml) 
Mw (g/mol) 
Rw (nm) 
 (log Rw/log Mw) 
28.11  0.47 
261.52.9 
89.3  22.7 
8.70.1 
2.2x10
6  0.6x106 
42.0  1.7 
0.26  0.02 
35.83  0.07 
33.36.4 
10.7  2.1 
1.10.2 
5.6x10
4  0.8x104 
36.0  3.6 
0.33  0.01 
a
 Abundance = amount (g) of each peak divided by the total amount (peak 2 + peak 3) 
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